Joint Research with the iPS Cell Research Institute and Diabetes Treatment Research

「Cellpro Japan is conducting research and development into cell-culture methods, the production of conditioned media, a new technology for extracting high concentrations of IL1-ra, an anti-inflammatory component, and formulation technologies combining new ingredients, while pursuing patent applications and grants for each.」

「We have entered into a joint research agreement with the Center for iPS Cell Research and Application at Kyoto University to build the fundamental technology needed to develop a novel treatment using the properties of human stem-cell-derived bioactive substances to improve brain function in neurological diseases. We also plan to begin research and development aimed at restoring insulin-producing function as a fundamental treatment for diabetes, for which cell therapy has shown some efficacy.」